- Metabolite
- HMDB0061112 (3-Carboxy-4-methyl-5-propyl-2-furanpropionic acid)
- Biospecimen
- Blood
- Status
- Detected and Quantified
- Data source
- Referenced
- Concentration
- 27.3 +/- 35.9 uM
- Age
- Adult (>18 years old)
- Sex
- Both
- Condition
- End-stage renal failure
References
- Sun H, Frassetto LA, Huang Y, Benet LZ: Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease. Clin Pharmacol Ther. 2010 Apr;87(4):465-72. doi: 10.1038/clpt.2009.247. Epub 2010 Jan 20. [PubMed:20090676 ]